It pains to have to write this, but I have decided to pause the premium membership component of The Antagonist.
Recent developments in my “day job” (I’m the CEO of a consulting firm) have required an…
Antagonist Stocks and Options Research · Dec 21, 2024
This site does not allow itself to be embedded. You can still read it on the original site — the toolbar below keeps your place in the directory.
I'm pausing Premium Memberships
It pains to have to write this, but I have decided to pause the premium membership component of The Antagonist.
Recent developments in my “day job” (I’m the CEO of a consulting firm) have required an…
Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.